Royal Bank Of Canada I Bio, Inc. Transaction History

Royal Bank Of Canada

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.23 - $160.0 $1 - $960	6 Added 0.15%	4,006 $1,000
Q2 2022 Aug 15, 2022	SELL	$0.23 - $0.46 $3,053 - $6,107	-13,278 Reduced 76.85%	4,000 $1,000
Q1 2022 May 16, 2022	SELL	$0.3 - $0.61 $9,176 - $18,659	-30,589 Reduced 63.9%	17,278 $8,000
Q4 2021 Feb 14, 2022	BUY	$0.55 - $1.04 $8,669 - $16,393	15,763 Added 49.1%	47,867 $26,000
Q3 2021 Nov 15, 2021	BUY	$1.06 - $1.52 $5,835 - $8,367	5,505 Added 20.7%	32,104 $34,000
Q2 2021 Aug 16, 2021	BUY	$1.22 - $1.65 $32,450 - $43,888	26,599 New	26,599 $40,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $24M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.